Author

Nancy Xie

Observed institutions: Ionis Pharmaceuticals (United States), Abbott (United States)

OpenAlex ID: A5010161697

PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice

2002 · Bradley A. Zinker, Cristina M. Rondinone, et al. · Proceedings of the National Academy of Sciences · 416

A potent erythropoietin-mimicking human antibody interacts through a novel binding site

2007 · Zhihong Liu, Vincent S. Stoll, et al. · Blood · 43

The Potency of Erythropoietin-Mimic Antibodies Correlates Inversely with Affinity

2008 · Susan E Lacy, Peter J DeVries, et al. · The Journal of Immunology · 28

PTP1B antisense oligonucleot normalizes blood glucose, an sensitivity in diabetic mice

2016 · Bradley A. Zinker, Cristina M. Rondinone, et al.

A potent erythropoietin mimic human antibody interacts through a novel binding site Running titile: EPOR AB ACTIVATES THROUGH A NOVEL BINDING SITE

2007 · David A. Egan, John E. Harlan, et al.

Circulating endothelial cells in preclinical models of cancer

2006 · Evelyn McKeegan, Daniel H. Albert, et al. · Clinical Cancer Research

Works count: 6

Citation count: 487

H-index: 3

I10-index: 3